LEVIOSA: LEVOFLOXACIN-DEXAMETHASONE (OPHTHALMOLOGY, OCULAR INFECTION AND INFLAMMATION, CATARACT SURGERY)

LEVIOSA: LEVOFLOXACIN-DEXAMETHASONE (OPHTHALMOLOGY, OCULAR INFECTION AND INFLAMMATION, CATARACT SURGERY)
Product Description

Levofloxacin-Dexamethasone eye drops solution is the first combination approved for the management of patients undergoing cataract surgery able to prevent infection and ensure complete control of inflammation with one week treatment. Levofloxacin-Dexamethasone combines the power of the most active steroid (Dexamethasone 0,1%) and Levofloxacin 0,5%, a fluoroquinolone with a broad spectrum of action and activity on bacteria (Gram+ and Gram-) most frequently implicated in ocular infections. Levofloxacin-Dexamethasone indication is based on published Leader7 clinical study: an International, multicenter, randomized, blinded-assessor, parallel-group clinical study performed on more than 800 patients.

-           7 Scientific publication available

Presentation: eyedrops MD and SDU.IP protected.

NTC S.r.l.

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

NTC S.r.l.

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from NTC S.r.l. (28)

NTC S.r.l. resources (7)